Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors
ContributorsCenni, Bruno; Picard, Didier
Published inBiochemical and biophysical research communications, vol. 261, no. 2, p. 340-344
Publication date1999
Abstract
Keywords
- Cell Line
- Cell Nucleus/metabolism
- Enzyme Inhibitors/chemistry/metabolism/pharmacology
- Estradiol Congeners/chemistry/metabolism/pharmacology
- Estrenes/chemistry/metabolism/pharmacology
- Humans
- Pyrrolidinones/chemistry/metabolism/pharmacology
- Receptors, Estrogen/agonists/genetics/metabolism
- Transfection
- Type C Phospholipases/antagonists & inhibitors
Affiliation entities
Citation (ISO format)
CENNI, Bruno, PICARD, Didier. Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors. In: Biochemical and biophysical research communications, 1999, vol. 261, n° 2, p. 340–344. doi: 10.1006/bbrc.1999.1017
Main files (1)
Article (Published version)
Identifiers
- PID : unige:4633
- DOI : 10.1006/bbrc.1999.1017
- PMID : 10425187
Journal ISSN0006-291X
